Catalog No.
FHD74114
Species reactivity
Human
Host species
Mouse
Isotype
IgG2b, kappa
Clonality
Monoclonal
Conjugation
PerCP
Applications
FCM
Target
TP103, Dipeptidyl peptidase IV, ADABP, Dipeptidyl peptidase 4, CD26, DPP4, Dipeptidyl peptidase IV soluble form, Dipeptidyl peptidase IV membrane form, DPP IV, ADCP2, Adenosine deaminase complexing protein 2, ADCP-2, T-cell activation antigen CD26
Concentration
0.5 mg/ml
Endotoxin level
Please contact with the lab for this information.
Accession
P27487
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Stability and Storage
Store at 4°C for 12 months. Protect from light. Do not freeze.
Clone ID
SAA0009
Note
For research use only.
Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer., PMID:37115489
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients., PMID:37170241
The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease., PMID:37350750
Analysis of IL-10 and IL-35 in dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:37424368
Discovery of novel thymidylate synthase (TS) inhibitors that influence cancer angiogenesis and metabolic reprogramming in NSCLC cells., PMID:37437348
Comprehensive cell surface protein profiling of human mesenchymal stromal cells from peritoneal dialysis effluent and comparison with those from human bone marrow and adipose tissue., PMID:37603218
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies., PMID:37626869
Dipeptidyl peptidase-4 inhibitor-related pemphigus herpetiformis with antibodies against desmocollin 3., PMID:37680081
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus., PMID:37756379
Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report., PMID:38035149
A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine., PMID:38036004
In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869., PMID:38067159
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid., PMID:38069109
Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease., PMID:38094101
A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration., PMID:38214494
Association of COVID with Mycosis in General., PMID:38251692
Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology., PMID:38266107
HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation., PMID:38284882
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks., PMID:38371953
DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model., PMID:38672409
Inactivated Split MERS-CoV Antigen Prevents Lethal Middle East Respiratory Syndrome Coronavirus Infections in Mice., PMID:38675818
A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus., PMID:38697296
Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants., PMID:38723671
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review., PMID:38753071
A case of immunoglobulin G4-related kidney disease manifesting after dipeptidyl peptidase-4 inhibitor treatment., PMID:38801515
ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB., PMID:38915783
Phenotypic characterisation of bovine alveolar macrophages reveals two major subsets with differential expression of CD163., PMID:38951667
Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy., PMID:39001488
CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: From interconnected signalling pathways to therapeutic strategies., PMID:39009062
Peptide array screening with anti-GLP-1 monoclonal antibody: Discovery of cysteine-containing DPP-IV inhibitory peptides., PMID:39085020
Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes., PMID:39099829
A Retrospective Comparison of Diagnostic Tools of Bullous Pemphigoid for Elderly Patients., PMID:39108027
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge., PMID:39189731
Cold-adapted live attenuated MERS-CoV vaccine strain remains attenuated in mice after multiple passages in Vero cells at 37 °C., PMID:39240318
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:39428667
Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study., PMID:39442884
Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function., PMID:39462543
Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes., PMID:39582250
Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells., PMID:39631769
Detection and Evaluation of Procalcitonin Variants As Diagnostic Tools in Systemic Inflammation., PMID:39636188
Vitamin D Supplementation as a Therapeutic Strategy in Autoimmune Diabetes: Insights and Implications for LADA Management., PMID:39683465
Dipeptidyl peptidase 4 is a cofactor for porcine epidemic diarrhea virus infection., PMID:39765007
Bullous pemphigoid: A practical approach to diagnosis and management in the modern era., PMID:39914667
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses., PMID:39922192
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution., PMID:40027745
Gastroprotective Effect of Linagliptin on Indomethacin-Induced Gastric Ulceration in Mice: Crosstalk Between Oxidative Stress and Inflammasome Pathways., PMID:40109745
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution., PMID:40162213
Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses., PMID:40226608
Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy., PMID:40238455
Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy., PMID:40494025
For research use only. Not for human or drug use.
